Shareholder alert: ademi llp investigates whether abiomed, inc. has obtained a fair price in its transaction with johnson & johnson

Milwaukee , nov. 1, 2022 /prnewswire/ -- ademi llp is investigating abiomed (nasdaq: abmd) for possible breaches of fiduciary duty and other violations of law in its transaction with johnson & johnson.  click here to learn how to join the action https://www.ademilaw.com/case/abiomed-inc or call guri ademi toll-free at 866-264-3995.
ABMD Ratings Summary
ABMD Quant Ranking